Cross Country Healthcare - CCRN Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $38.50
  • Forecasted Upside: 24.27%
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$30.98
▲ +1.07 (3.58%)

This chart shows the closing price for CCRN by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Cross Country Healthcare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CCRN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CCRN

Analyst Price Target is $38.50
▲ +24.27% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Cross Country Healthcare in the last 3 months. The average price target is $38.50, with a high forecast of $45.00 and a low forecast of $31.00. The average price target represents a 24.27% upside from the last price of $30.98.

This chart shows the closing price for CCRN for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 4 polled investment analysts is to buy stock in Cross Country Healthcare. This rating has held steady since September 2021, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 1 sell ratings
8/14/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
11/12/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
2/10/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
5/11/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
8/9/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
11/7/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
1/6/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
2/5/2023

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/24/2022Credit Suisse GroupBoost Target$31.00Low
11/7/2022Barrington ResearchBoost TargetOutperform$41.00 ➝ $45.00Low
10/5/2022Truist FinancialDowngradeBuy ➝ Hold$36.00Low
9/15/2022BenchmarkBoost TargetBuy$37.00 ➝ $42.00Low
8/22/2022Barrington ResearchLower Target$40.00Low
6/13/2022BenchmarkLower TargetBuy$42.00 ➝ $37.00High
6/9/2022Credit Suisse GroupLower TargetNeutral$28.00 ➝ $26.00High
4/11/2022Barrington ResearchBoost Target$33.00 ➝ $44.00Low
2/24/2022BenchmarkBoost TargetBuy$33.00 ➝ $42.00High
1/27/2022Jefferies Financial GroupUpgradeHold ➝ Buy$18.00 ➝ $27.00High
11/18/2021Barrington ResearchBoost TargetOutperform$22.00 ➝ $33.00Medium
8/31/2021Truist FinancialBoost TargetBuy$19.00 ➝ $23.00Medium
8/18/2021Barrington ResearchReiterated RatingBuy$17.00High
8/16/2021Credit Suisse GroupBoost TargetNeutral$13.50 ➝ $19.00High
8/5/2021BenchmarkUpgradeHold ➝ Buy$22.00High
6/14/2021BMO Capital MarketsBoost TargetOutperform$17.00 ➝ $20.00Low
5/21/2021Barrington ResearchBoost TargetOutperform$14.00 ➝ $17.00Low
5/12/2021BenchmarkReiterated RatingBuy ➝ HoldHigh
5/6/2021Credit Suisse GroupBoost TargetNeutral$11.00 ➝ $13.50Medium
5/6/2021BenchmarkDowngradeBuy ➝ HoldHigh
2/25/2021Credit Suisse GroupBoost TargetNeutral$10.00 ➝ $11.00High
2/22/2021Barrington ResearchReiterated RatingBuy$12.00Medium
11/23/2020BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$10.00Medium
11/5/2020Credit Suisse GroupBoost TargetNeutral$7.00 ➝ $8.50High
11/5/2020BMO Capital MarketsBoost TargetMarket Perform$7.00 ➝ $9.00Medium
11/5/2020BenchmarkUpgradeHold ➝ Buy$11.00High
10/30/2020Truist FinancialUpgradeHold ➝ Buy$7.00 ➝ $10.00High
10/8/2020Bank of AmericaInitiated CoverageUnderperform$7.50High
8/17/2020OppenheimerReiterated RatingHold ➝ NeutralMedium
8/12/2020Barrington ResearchReiterated RatingBuy$9.00Medium
8/6/2020Credit Suisse GroupBoost TargetNeutral$6.50 ➝ $7.00High
5/18/2020Barrington ResearchLower TargetOutperform$11.00 ➝ $9.00Medium
5/15/2020OppenheimerReiterated RatingHoldLow
5/8/2020SunTrust BanksLower TargetHold$9.00 ➝ $7.00Low
3/26/2020SunTrust BanksLower TargetHold$12.00 ➝ $9.00High
3/10/2020Barrington ResearchReiterated RatingOutperformHigh
5/20/2019Barrington ResearchSet TargetBuy$10.00Medium
2/28/2019BMO Capital MarketsLower TargetMarket Perform ➝ Market Perform$10.00 ➝ $8.00Medium
2/19/2019SunTrust BanksDowngradeBuy ➝ HoldHigh
11/15/2018Barrington ResearchSet TargetBuy$11.00Medium
11/5/2018BMO Capital MarketsBoost TargetMarket Perform ➝ Market Perform$9.00 ➝ $10.00High
11/2/2018Lake Street CapitalUpgradeHold ➝ Buy$10.00 ➝ $12.00High
10/2/2018StephensInitiated CoverageEqual WeightLow
9/19/2018Barrington ResearchSet TargetBuy$13.00Medium
8/9/2018Barrington ResearchReiterated RatingOutperformLow
8/2/2018Credit Suisse GroupLower TargetNeutral ➝ Neutral$11.50 ➝ $9.00High
8/2/2018BMO Capital MarketsDowngradeOutperform ➝ Market Perform$13.00High
8/1/2018Cantor FitzgeraldReiterated RatingNeutral ➝ Hold$11.00 ➝ $10.00High
5/22/2018Barrington ResearchReiterated RatingBuy$15.00Low
5/7/2018Cantor FitzgeraldReiterated RatingHold$11.00High
5/3/2018Lake Street CapitalDowngradeBuy ➝ Hold$16.00 ➝ $11.00High
4/18/2018Barrington ResearchInitiated CoverageOutperform$15.00Medium
3/6/2018BMO Capital MarketsReiterated RatingOutperform ➝ Outperform$14.00 ➝ $13.00Medium
3/2/2018Lake Street CapitalReiterated RatingBuy ➝ HoldHigh
3/2/2018Cantor FitzgeraldDowngradeOverweight ➝ NeutralHigh
3/2/2018SunTrust BanksReiterated RatingBuyHigh
3/1/2018BenchmarkDowngradeBuy ➝ Hold$19.00High
(Data available from 2/5/2018 forward)

News Sentiment Rating

0.81 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 9 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
7/10/2022
  • 2 very positive mentions
  • 13 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
8/9/2022
  • 8 very positive mentions
  • 6 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
9/8/2022
  • 10 very positive mentions
  • 17 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
10/8/2022
  • 7 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/7/2022
  • 10 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/7/2022
  • 2 very positive mentions
  • 5 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
1/6/2023
  • 9 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
2/5/2023

Current Sentiment

  • 9 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Cross Country Healthcare logo
Cross Country Healthcare, Inc. engages in the provision of healthcare staffing and workforce management solutions. It operates through the following segments: Nurse and Allied Staffing, Physician Staffing, and Search. The Nurse and Allied Staffing segment provides workforce solutions and traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, branch-based local nurses, and allied staffing. The Physician Staffing segment consists of certified registered nurse anesthetists, nurse practitioners, and physician assistants. The Search segment serve as a direct-hire talent acquisition partner to healthcare organizations and academic institutions throughout the nation providing a full suite of prescriptive talent management solutions, including flexible talent delivery models such as retained, outsourced, and contingent. The company was founded by Kevin C. Clark in 1986 and is headquartered in Boca Raton, FL.
Read More

Today's Range

Now: $30.98
Low: $29.52
High: $31.24

50 Day Range

MA: $29.12
Low: $26.17
High: $36.64

52 Week Range

Now: $30.98
Low: $15.26
High: $40.12

Volume

717,727 shs

Average Volume

493,198 shs

Market Capitalization

$1.16 billion

P/E Ratio

5.14

Dividend Yield

N/A

Beta

1.04

Frequently Asked Questions

What sell-side analysts currently cover shares of Cross Country Healthcare?

The following equities research analysts have issued stock ratings on Cross Country Healthcare in the last year: Barrington Research, Benchmark Co., Credit Suisse Group AG, StockNews.com, and Truist Financial Co..
View the latest analyst ratings for CCRN.

What is the current price target for Cross Country Healthcare?

4 Wall Street analysts have set twelve-month price targets for Cross Country Healthcare in the last year. Their average twelve-month price target is $38.50, suggesting a possible upside of 24.3%. Barrington Research has the highest price target set, predicting CCRN will reach $45.00 in the next twelve months. Credit Suisse Group AG has the lowest price target set, forecasting a price of $31.00 for Cross Country Healthcare in the next year.
View the latest price targets for CCRN.

What is the current consensus analyst rating for Cross Country Healthcare?

Cross Country Healthcare currently has 2 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CCRN will outperform the market and that investors should add to their positions of Cross Country Healthcare.
View the latest ratings for CCRN.

What other companies compete with Cross Country Healthcare?

How do I contact Cross Country Healthcare's investor relations team?

Cross Country Healthcare's physical mailing address is 5201 CONGRESS AVENUE SUITE 100B, BOCA RATON FL, 33487. The business services provider's listed phone number is (561) 998-2232 and its investor relations email address is [email protected] The official website for Cross Country Healthcare is www.crosscountryhealthcare.com. Learn More about contacing Cross Country Healthcare investor relations.